Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000418538 | SCV000228269 | uncertain significance | not provided | 2015-02-04 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000222871 | SCV000268897 | benign | not specified | 2015-10-11 | criteria provided, single submitter | clinical testing | c.2017-5T>G in intron 25 of COL11A2: This variant is not expected to have clinic al significance because it has been identified in 0.88% (133/15120) of South Asi an chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinsti tute.org; dbSNP rs200523422). |
Center for Pediatric Genomic Medicine, |
RCV000418538 | SCV000511840 | likely benign | not provided | 2017-01-24 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Gene |
RCV000418538 | SCV000726610 | likely benign | not provided | 2021-06-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000418538 | SCV002402714 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002277379 | SCV002567194 | likely benign | Connective tissue disorder | 2019-12-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003977437 | SCV004792627 | likely benign | COL11A2-related disorder | 2020-03-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |